Effect of a Single Ultra-Processed Meal on Myocardial Endothelial Function Assessed With Positron Emission Tomography
SUPPER
1 other identifier
interventional
15
1 country
1
Brief Summary
The objective of this study is to evaluate the effect of an ultra-processed meal on myocardial endothelial function using positron emission tomography (PET). The proposed study is an open-label, randomized crossover clinical trial. Participants will be divided into 2 groups: half of the participants will consume a Mediterranean meal during the first experimental visit and an ultra-processed meal during the second, and vice versa for the other half. The order in which the meals will be consumed will be determined randomly. This project will contribute to clarify the role of diet in the development and progression of coronary artery disease. The results obtained from this study may potentially demonstrate the harmful effect of ultra-processed foods, even in the short term, on coronary arteries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 20, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 28, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 28, 2023
CompletedFirst Submitted
Initial submission to the registry
March 15, 2024
CompletedFirst Posted
Study publicly available on registry
April 8, 2024
CompletedApril 8, 2024
April 1, 2024
2.7 years
March 15, 2024
April 3, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Myocardial blood flow values (ml/min/g) at maximum dose of adenosine.
The difference in maximum dose adenosine myocardial blood flow measured after consumption of ultra-processed (NOVA 4) and Mediterranean meals (NOVA 1-3) in healthy subjects.
4 hours after meal consumption
Secondary Outcomes (2)
Myocardial blood flow values (ml/min/g) at rest and myocardial reserve.
4 hours after meal consumption
Myocardial blood flow values (ml/min/g) at intermediate dose of adenosine.
4 hours after meal consumption
Interventions
NOVA (a name, not an acronym) is a food classification system divided into four groups, based on the level of processing. Group 4 - Ultra-processed foods. They are the ones that use many ingredients including food additives that improve palatability, processed raw materials (hydrogenated fats, modified starches, etc.) and ingredients that are rarely used in home cooking such as soy protein or mechanically separated meat. These foods are mainly of industrial origin and are characterized by a good pleasantness and the fact that they can be stored for a long time.
NOVA (a name, not an acronym) is a food classification system divided into four groups, based on the level of processing. Group 1 - Unprocessed or minimally processed foods (fruit, vegetables, eggs, meat, milk, etc.) Group 2 - Foods processed in the kitchen with the aim of extending their shelf life. In practice, these are ingredients to be used in the kitchen such as fats, aromatic herbs, etc. to be kept in jars or in the refrigerator to be able to use them later. Group 3 - Processed foods. These are the foods obtained by combining foods of groups 1 and 2 to obtain the many food products for domestic use (bread, jams, etc.) made up of a few ingredients
Eligibility Criteria
You may qualify if:
- Men aged between 18 and 50 years.
- Absence of cardiovascular symptoms.
- Ability to provide free and informed consent.
You may not qualify if:
- Presence of cardiovascular disease.
- Active smoking or within the past 12 months.
- Hypertension (BP \> 140/90 mmHg).
- Renal failure (Creatinine clearance \< 90 mL/min).
- Type I or II diabetes.
- Dyslipidemia (LDL ≥ 3.5 mmol/L or total cholesterol/HDL ratio ≥ 5.0).
- Heart failure (Left ventricular ejection fraction \< 50%).
- Congenital heart disease.
- Obesity (BMI \> 35 kg/m2).
- Uncontrolled asthma or chronic obstructive pulmonary disease (COPD).
- History of severe allergy or reaction to adenosine or dipyridamole.
- Second-degree type II or third-degree atrioventricular block.
- Bradycardia with resting heart rate \< 40 bpm.
- Chronic alcoholism.
- Substance abuse.
- +7 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Matthieu Pelletier-Galarneau
Montreal, Quebec, H1T 1C8, Canada
Related Publications (1)
Lucinian YA, Gagnon C, Latour E, Hamel V, Iglesies-Grau J, Nigam A, Harel F, Nozza A, Juneau M, Moubarac JC, Bherer L, Pelletier-Galarneau M. Effect of a single ultra processed meal on myocardial endothelial function, adenosine mediated effects and cognitive performances. Sci Rep. 2025 Aug 6;15(1):28671. doi: 10.1038/s41598-025-11734-z.
PMID: 40764338DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Matthieu Pelletier-Galarneau
Montreal Heart Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Chief, division of nuclear medicine at Institut de cardiologie de Montreal
Study Record Dates
First Submitted
March 15, 2024
First Posted
April 8, 2024
Study Start
August 20, 2020
Primary Completion
April 28, 2023
Study Completion
April 28, 2023
Last Updated
April 8, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share